4552.T
JCR Pharmaceuticals Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 527.00
+0.76%Price chart
Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
36.0x
EV/EBITDA
24.1x
Market Cap
JPY 64.29B
MomentumView details →
1D Return
+0.76%
YTD Return
−26.26%
RSI (14)
52.3
ValuationView details →
P/E (Fwd)
36.0x
EV/EBITDA
24.1x
Market Cap
JPY 64.29B
RSI (14)
52.3
MomentumView details →
1D Return
+0.76%
YTD Return
−26.26%
Similar companies
Latest newsMore news →
Acumen Pharmaceuticals exercised its exclusive option to develop therapeutic candidates for Alzheimer's disease using JCR Pharmaceuticals' J-Brain Cargo technology platform.79d agoAcumen Pharmaceuticals nominated two development candidates, ACU301 and ACU401, in its Enhanced Brain Delivery program for Alzheimer's disease treatment.80d ago